Project
PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Completed · 2012 until 2017
Müller Rüdiger, Forrer Silvia
Type
Range
Units
Status
Start Date
End Date
Financing
Study Design
Homepage
Brief description/objective
Official Title:
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Two Doses Of Apremilast (CC-10004) In Subjects With Active Psoriatic Arthritis And A Qualifying Psoriasis Lesion
Purpose:
The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis and a qualifying psoriasis lesion.
Apremilast is proposed to improve signs and symptoms of psoriatic arthritis (tender and swollen joints, pain, physical function) in treated patients.